Letrozole
Presentación: 60tb
Referencia del proveedor: Letro-Med
Product Description: Letro-med by Bioniche Pharma contains Letrozole (2.5 mg per tablet), a potent, non-steroidal third-generation aromatase inhibitor (AI). Medically indicated for hormone-receptor-positive breast cancer, it works by competitively binding to the aromatase enzyme, effectively blocking the conversion of androgens to estrogens and reducing systemic estrogen levels by up to 98%.
Bodybuilding Administration Protocol: Due to its extreme potency, athletes typically use it to combat severe estrogenic side effects (gynecomastia and water retention) during aromatizable anabolic steroid cycles.
Standard Mitigation Dosage: 0.5 mg to 1 mg taken twice weekly, or 0.25 mg every other day, adjusted according to blood serum estradiol levels.
Emergency Gynecomastia Protocol (Reversal attempt): 2.5 mg per day until symptoms recede, followed by a rapid taper to avoid an estrogen rebound effect.